Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Michelle Lee, Author at ViewusGlobal

Michelle Lee (191 Posts)

  • Got a Family History of Rare Dementia? This Gene Might Protect You New research highlights the importance of genetic testing for protective mutations in hereditary frontotemporal dementia to delay disease onset.
  • Living Near a Golf Course? Your Risk for Parkinson’s Might Be Higher Living near golf courses may significantly increase the risk of developing Parkinson's disease, linked to pesticide exposure.
  • Still Tired After 8 Hours of Sleep? This Could Be Why Sleep apnea disrupts sleep quality, causing fatigue and serious health risks. Diagnosis and treatment are crucial for effective management.
  • Scientists Link Let-7 Gene to Lung Healing—and Possibly a Cure for Fibrosis A study reveals the let-7 gene's crucial role in lung recovery and pulmonary fibrosis, highlighting its importance in preventing lung damage.
  • New Brain Cancer Drug Taps Into the Body's Internal Clock SHP1705 shows promise in inhibiting glioblastoma stem cells by targeting circadian clock proteins, enhancing cancer treatment efficacy.
  • Fatigue Fighters? Scientists Zero In on Hidden Energy Regulators Research reveals estrogen-related receptors' role in muscle fatigue recovery, offering insights for metabolic disorder treatments.
  • Snoring May Be Hurting Your Memory More Than You Think Obstructive sleep apnea significantly contributes to memory loss, highlighting the need for better diagnostics and treatments.
  • This Simple Habit Could Lower Heart Failure Death Risk From 21% to 11% A study reveals only 3 in 5 heart failure patients consult cardiologists, highlighting the need for regular specialist care.
  • This One Ratio Could Be the Key to Spotting Heart Failure Early A study reveals that waist-to-height ratio (WtHR) is a better predictor of heart failure risk than BMI, highlighting central fat's dangers.
  • Study Suggests DNA Tweaks Could Be Behind Tough-to-Treat Lymphoma New research reveals epigenetic changes are crucial in lymphoma development, suggesting potential new treatment avenues with HDAC inhibitors.
  • Ditch the Glasses? Here’s What to Know Before Getting LASIK or LASEK Increased smartphone and computer use is leading to more people experiencing vision problems, prompting interest in corrective eye surgery.
  • Forget 10,000 Steps—Here’s How Many You Actually Need for Better Health Brisk walking significantly reduces health risks and can lower biological age, but offers no extra benefits over regular walking for cancer risk.
  • Pregnant With Liver Disease? You May Face Higher Risk of Preterm Birth Pregnant women with MASLD face a threefold increased risk of preterm birth, highlighting the need for specialized monitoring and guidelines.
  • New Psoriasis Foam Cuts Itch and Clears Skin, Study Says A new study shows roflumilast foam treats plaque psoriasis on the scalp, offering significant relief and improved quality of life.
  • New Study Finds Protein That Could Help Fight Age-Related Muscle Loss A study reveals HDAC11 protein may combat age-related muscle decline, offering hope for sarcopenia treatment in older adults.
  • Doctors Warn: Common Hypertension Test Could Be Leading Us Astray A study reveals that a common hypertension diagnostic tool may misdiagnose patients, risking missed treatment for heart health.
  • New Treatment Could Stop Cold Sores and Shingles Before They Start New treatment GS-1 shows promise against shingles and cold sores, potentially reducing symptoms and transmission of these viral infections.
  • Heart Failure Risk May Be Written in Your DNA, Study Says A study reveals that both common and rare genetic variations can help accurately classify heart failure risk among patients.
  • Neuralink Gets Green Light From FDA to Accelerate Speech-Restoring Tech Neuralink's device receives FDA "breakthrough approval" to aid those with severe speech impairments due to neurological disorders.
  • FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder The FDA has approved Zevaskyn for treating recessive dystrophic epidermolysis bullosa, a rare skin condition, promising improved healing.
1 2 3 4 5 6 10